An Update on Lecanemab for Early Stage Alzheimer’s Disease
On Wed. September 26, 2024, the UW Memory and Brain Wellness Center hosted a webinar titled, An Update on Lecanemab for Early Stage Alzheimer’s Disease Patients, families, and the wider community are invited to talk about the current amyloid-clearing infusion medications Leqembi (lecanemab) and Kisunla (donanemab) for the treatment of Alzheimer's. Come learn from our panel of experts which include, Dr. Thomas Grabowski, Dr. Michael Rosenbloom and clinical trials coordinator Darla Chapman, ARNP. • Who is eligible for these treatments? • What are the risks and benefits? • What is the process if you're interested in these medications? • What is the impact of these medications as well as similar ones in the pipeline for the clinic community and research? • How has it been going for those patients who have been given the Leqembi infusion? Hosted by the UW Memory and Brain Wellness Center | uwmemoryandbrain.org
"Developments in Alzheimer’s Disease:From Diagnosis to Treatment" | 7 May2025
Alzheimer’s Clinical Trials 2026: An Insider’s Look with Dr. Jeffrey Cummings
The Groundbreaking Alzheimer's Study You Need To Hear About
Leqembi Vs Donanemab: Cure for Alzheimer's?
Lecanemab vs. Donanemab: Expert Breakdown of Alzheimer’s Treatments | Dr. Khushboo Verma
The New Alzheimer's Drug Leqembi Explained
Alzheimer's Disease - Amyloidopathy (Part 2)
The Next Generation of Alzheimer’s Treatments
Alzheimer's Disease - The amyloid cascade, alternative mechanisms (Part 1)
'Miracle' drug giving hope to Alzheimer's sufferers | 60 Minutes Australia
Inside Alzheimer’s Research: New Medications and Innovative Care
Alzheimer's is 'Type 3 Diabetes' (The REAL Root Cause of Brain Fog)
Leqembi and Kisunla: Your Questions Answered
UW ECHO Dementia October 10, 2025: Blood Biomarkers for Alzheimer's in Current Practice
What You Can Do to Prevent Alzheimer's | Lisa Genova | TED
The New Alzheimer’s Drug: What is Kisunla?
Alzheimer's: The Caregiver's Perspective
Do You Qualify for Lecanemab or Donanemab? Alzheimer’s Breakthroughs | Dr. Khushboo Verma
Diagnosing Alzheimer’s Disease
